Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
Want to see ZNTL full AI Analyst Report?
Zentalis Pharmaceuticals (ZNTL) Ownership Overview
30.04% Insiders
5.79% Mutual Funds
0.01% Other Institutional Investors
4.40% ETFs
59.75% Public Companies and
Individual Investors
The ownership structure of Zentalis Pharmaceuticals (ZNTL) stock is a mix of institutional, retail, and individual investors. Approximately 10.21% of the company’s stock is owned by Institutional Investors, 30.04% is owned by Insiders, and 59.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 10, 2026 | xxxxxxxxxxxxx | $7969 | |
Feb 10, 2026 | xxxxxxxxxxxxx | $21160 | |
Feb 10, 2026 | xxxxxxxxxxxxx | $80557 | |
Feb 04, 2026 | xxxxxxxxxxxxx | $6477 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $1292517 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $122729 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,959,973 | Institution | 19.68% | 59,329,885 | |
| 13,509,973 | Insider | 19.05% | 57,417,385 | |
| 6,459,973 | Insider | 9.11% | 27,454,885 | |
| 2,389,453 | Institution | 3.37% | 10,155,175 | |
| 2,131,700 | Institution | 3.01% | 9,059,725 | |
| 957,420 | Institution | 1.35% | 4,069,035 | |
| 676,400 | Institution | 0.95% | 2,874,700 | |
| 530,582 | Institution | 0.75% | 2,254,974 | |
| 475,060 | Institution | 0.67% | 2,019,005 | |
| 338,795 | Insider | 0.48% | 1,439,879 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,131,700 | Institution | 3.01% | 9,059,725 | |
| 676,400 | Institution | 0.95% | 2,874,700 | |
| 475,060 | Institution | 0.67% | 2,019,005 | |
| 209,330 | Institution | 0.30% | 889,653 | |
| 159,467 | Institution | 0.22% | 677,735 | |
| 137,162 | Institution | 0.19% | 582,939 | |
| 108,264 | Institution | 0.15% | 460,122 | |
| 77,300 | Institution | 0.11% | 328,525 | |
| 38,041 | Institution | 0.05% | 161,674 | |
| 34,483 | Institution | 0.05% | 146,553 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,694,426 | Institution | 2.39% | 3,964,957 | |
| 543,757 | Institution | 0.77% | 1,272,391 | |
| 247,993 | Institution | 0.35% | 987,012 | |
| 160,998 | Institution | 0.23% | 640,772 | |
| 151,270 | Institution | 0.21% | 353,972 | |
| 125,701 | Institution | 0.18% | 534,229 | |
| 81,063 | Institution | 0.11% | 322,631 | |
| 61,062 | Institution | 0.09% | 259,514 | |
| 54,087 | Institution | 0.08% | 215,266 | |
| 2,171 | Institution | <0.01% | 38,969 |
FAQ
Who Owns Zentalis Pharmaceuticals (ZNTL)?
According to the latest TipRanks data, approximately 0.01% of the company's stock is held by institutional investors, 30.04% is held by insiders, and 59.75% is held by retail investors.
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.01% of Zentalis Pharmaceuticals (ZNTL) stock is held by institutional investors.
What percentage of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.75% of Zentalis Pharmaceuticals (ZNTL) stock is held by retail investors.
Who owns the most shares of Zentalis Pharmaceuticals (ZNTL)?
Christopher J. Burke owns the most shares of Zentalis Pharmaceuticals (ZNTL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.